1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Bladder Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berthelsen, AK; Brandt-Larsen, M; Brasso, K; Christensen, C; Holm, S; Højgaard, L; Kjaer, A; Klausen, TL; Kroman, N; Loft, A; Madsen, J; Nielsen, CH; Pappot, H; Persson, M; Ploug, M; Skovgaard, D; Thurison, T | 1 |
Beck, A; Echner, H; Feil, G; Gharabaghi, A; Heckl, S; Nagele, T; Regenbogen, M; Sturzu, A | 1 |
1 trial(s) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Bladder Cancer
Article | Year |
---|---|
First-in-human uPAR PET: Imaging of Cancer Aggressiveness.
Topics: Breast Neoplasms; Copper Radioisotopes; Drug-Related Side Effects and Adverse Reactions; Female; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Molecular Imaging; Oligopeptides; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Protein Binding; Receptors, Urokinase Plasminogen Activator; Urinary Bladder Neoplasms | 2015 |
1 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Bladder Cancer
Article | Year |
---|---|
Value of apoptin's 40-amino-acid C-terminal fragment for the differentiation between human tumor and non-tumor cells.
Topics: Amino Acid Sequence; Apoptosis; Astrocytes; Brain; Capsid Proteins; Cell Line, Tumor; Cell Nucleus; Cells, Cultured; Dansyl Compounds; Flow Cytometry; Fluorescein-5-isothiocyanate; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Male; Microscopy, Confocal; Microscopy, Fluorescence; Nuclear Export Signals; Nuclear Localization Signals; Peptide Fragments; Phosphothreonine; Prostate; Prostatic Neoplasms; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2008 |